All Stories

  1. Differential Expression of Caveolin-3, Suppression of Tumorigenicity 2, and Growth Differentiation Factor-15 Genes and Their Association with Acute Myocardial Infarction: A Cross-Sectional Study in a Multi-Specialty Hospital in Tamil Nadu

    Article • Genetic Testing and Molecular Biomarkers, March 2023, Mary Ann Liebert Inc

    Dr Melvin George

  2. Role of Diospyros peregrina fruit preparation in suppressing regulatory T (Treg) cells in the tumor microenvironment of breast and lung cancer

    Article • Phytomedicine Plus, September 2022, Elsevier

    Dr Melvin George

  3. EVALUATION OF ADENOVIRAL VECTOR-BASED VACCINES FOR PREVENTION OF COVID-19 – AN OVERVIEW

    Article • Asian Journal of Pharmaceutical and Clinical Research, July 2022, Innovare Academic Sciences Pvt Ltd

    Dr Melvin George

  4. Extent of knowledge and attitudes on plagiarism among undergraduate medical students in South India - a multicentre, cross-sectional study to determine the need for incorporating research ethics in medical undergraduate curriculum

    Article • BMC Medical Education, May 2022, Springer Science + Business Media

    Dr Melvin George

  5. Usefullness of MicroRNAs in Predicting the Clinical Outcome of Patients with Acute Myocardial Infarction During Follow-Up: A Systematic Review

    Article • Genetic Testing and Molecular Biomarkers, May 2022, Mary Ann Liebert Inc

    Dr Melvin George

  6. Efficacy of pharmacological interventions in COVID‐19: A network meta‐analysis

    Article • British Journal of Clinical Pharmacology, April 2022, Wiley

    Dr Melvin George

  7. Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review

    Article • European Journal of Clinical Pharmacology, January 2022, Springer Science + Business Media

    Dr Melvin George

  8. Alirocumab in Post ACS Patients - Saving Lives at a Premium

    Article • Current Cardiology Reviews, January 2022, Bentham Science Publishers

    Dr Melvin George

  9. A Review of The Contribution of Gut-Dependent Microbiota Derived Marker, Trimethylamine N-oxide (TMAO), in Coronary Artery Disease

    Article • Current Research in Nutrition and Food Science Journal, December 2021, Enviro Research Publishers

    Dr Melvin George

  10. Long Term Prognostic Utility of Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome - A Systematic Review

    Article • Current Pharmaceutical Biotechnology, August 2021, Bentham Science Publishers

    Dr Melvin George

  11. Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges

    Article • Clinical Drug Investigation, March 2021, Springer Science + Business Media

    Dr Melvin George

  12. Novel and Re-emerging Zoonotic Viral Diseases in India during Last Two Decades: An Overview

    Article • Journal of Pharmaceutical Research International, March 2021, Sciencedomain International

    Dr Melvin George

  13. Avaliação da Senescência de Células Sanguíneas Mononucleares Periféricas e na Disfunção Endotelial entre Adultos com Alto Risco Cardiovascular

    Article • Arquivos Brasileiros de Cardiologia, January 2021, Sociedade Brasileira de Cardiologia

    Dr Melvin George

  14. The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy

    Article • Current Clinical Pharmacology, October 2019, Bentham Science Publishers

    Dr Melvin George

  15. Novel approaches in the treatment of diabetic cardiomyopathy

    Article • Biomedicine & Pharmacotherapy, October 2018, Elsevier

    Dr Melvin George

  16. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes

    Article • European Journal of Clinical Investigation, July 2018, Wiley

    Dr Melvin George

  17. Effect of metformin on exercise capacity in metabolic syndrome

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, November 2017, Elsevier

    Dr Melvin George

  18. Authors reply to “No, we are not—we keep forgetting the right ventricle”

    Article • European Journal of Clinical Pharmacology, October 2017, Springer Science + Business Media

    Dr Melvin George

  19. Do ANGPTL-4 and galectin-3 reflect the severity of coronary artery disease?

    Article • Therapeutic Advances in Cardiovascular Disease, August 2017, SAGE Publications

    Dr Melvin George

  20. Homocysteine-Is there any role in Coronary Heart Disease?

    Article • Journal of Cardiovascular Disease Research, July 2017, EManuscript Services

    Dr Melvin George

  21. A peek into the drug development scenario of endometriosis – A systematic review

    Article • Biomedicine & Pharmacotherapy, June 2017, Elsevier

    Dr Melvin George

  22. SCARB1 rs5888 c.1050C>T Polymorphism and the Risk of Hypercholesterolemia and Myocardial Infarction in Indian Tamil Population

    Article • Pakistan Journal of Zoology, May 2017, Smith and Franklin Academic Publishing Corporation, Ltd, UK

    Dr Melvin George

  23. End points in heart failure—are we doing it right?

    Article • European Journal of Clinical Pharmacology, March 2017, Springer Science + Business Media

    Dr Melvin George

  24. Molecular analysis of the LDLR gene in coronary artery disease patients from the Indian population

    Article • Clinical Biochemistry, June 2016, Elsevier

    Dr Melvin George

  25. Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial

    Article • Indian Heart Journal, April 2016, Elsevier

    Dr Melvin George

  26. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition—The Dream of Translational Medicine

    Article • Journal of Cardiovascular Pharmacology, February 2016, Wolters Kluwer Health

    Dr Melvin George

  27. GDF 15 - A Novel Biomarker in the Offing for Heart Failure

    Article • Current Cardiology Reviews, January 2016, Bentham Science Publishers

    Dr Melvin George

  28. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study

    Article • Therapeutic Advances in Cardiovascular Disease, March 2015, SAGE Publications

    Dr Melvin George

  29. Riociguat: Something new in pulmonary hypertension therapeutics?

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2015, Medknow

    Dr Melvin George

  30. Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2015, JCDR Research and Publications

    Dr Melvin George

  31. Pattern of Adverse Drug Reactions Reported with Cardiovascular Drugs in a Tertiary Care Teaching Hospital

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2015, JCDR Research and Publications

    Dr Melvin George

  32. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?

    Article • European Journal of Preventive Cardiology, September 2014, SAGE Publications

    Dr Melvin George

  33. Looking into the Crystal Ball—Upcoming Drugs for Dyslipidemia

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, July 2014, SAGE Publications

    Dr Melvin George

  34. Novel drug targets in clinical development for heart failure

    Article • European Journal of Clinical Pharmacology, April 2014, Springer Science + Business Media

    Dr Melvin George

  35. Pharmacovigilance for psychiatrists: An introduction

    Article • Indian Journal of Psychiatry, January 2014, Medknow

    Dr Melvin George, Dr Ravi Philip Rajkumar

  36. Clinical Trial Endpoints in Breast Cancer

    Article • January 2014, Springer Science + Business Media

    Dr Melvin George

  37. Assessment of Arterial Stiffness Index in Hypertensive Patients in Relation to Their Treatment Status Attending a Tertiary Care Center in South India

    Article • Pharmacology &amp Pharmacy, January 2014, Scientific Research Publishing, Inc,

    Dr Melvin George

  38. Noninvasive Nanodiagnostics for Cancer

    Article • December 2013, Taylor & Francis

    Dr Melvin George

  39. New and Emerging Drug Molecules Against Obesity

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, September 2013, SAGE Publications

    Dr Melvin George

  40. Newer antipsychotics and upcoming molecules for schizophrenia

    Article • European Journal of Clinical Pharmacology, April 2013, Springer Science + Business Media

    Dr Melvin George, Dr Ravi Philip Rajkumar

  41. Globalization of Clinical Trials – Where are We Heading?

    Article • Current Clinical Pharmacology, March 2013, Bentham Science Publishers

    Dr Melvin George

  42. Pharmacogenomics of Autoimmune Diseases

    Article • January 2013, Springer Science + Business Media

    Dr Melvin George

  43. The dawn of hedgehog inhibitors: Vismodegib

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2013, Medknow

    Dr Melvin George

  44. Pharmacogenomics in Type 2 Diabetes Mellitus and Metabolic Disorders

    Article • January 2013, Springer Science + Business Media

    Dr Melvin George

  45. Clinical trials in India: Where do we stand globally?

    Article • Perspectives in Clinical Research, January 2013, Medknow

    Dr Melvin George

  46. Belatacept: A worthy alternative to cyclosporine?

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2012, Medknow

    Dr Melvin George

  47. Authors′ reply

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2012, Medknow

    Dr Melvin George

  48. Effect of anti-tuberculosis therapy on polymorphic drug metabolizing enzyme CYP2C9 using phenytoin as a probe drug

    Article • Indian Journal of Pharmacology, January 2012, Medknow

    Dr Melvin George